DK244680A - Fremgangsmaade til fremstilling af antibiotika benaevnt a-30912samt de individuelle faktorer a-30912a,b,d og h. - Google Patents

Fremgangsmaade til fremstilling af antibiotika benaevnt a-30912samt de individuelle faktorer a-30912a,b,d og h.

Info

Publication number
DK244680A
DK244680A DK244680A DK244680A DK244680A DK 244680 A DK244680 A DK 244680A DK 244680 A DK244680 A DK 244680A DK 244680 A DK244680 A DK 244680A DK 244680 A DK244680 A DK 244680A
Authority
DK
Denmark
Prior art keywords
individual factors
antibiotics used
preparing antibiotics
preparing
factors
Prior art date
Application number
DK244680A
Other languages
Danish (da)
English (en)
Inventor
L V D Boeck
R E Kastner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK244680A publication Critical patent/DK244680A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/66Aspergillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK244680A 1979-06-08 1980-06-06 Fremgangsmaade til fremstilling af antibiotika benaevnt a-30912samt de individuelle faktorer a-30912a,b,d og h. DK244680A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4674479A 1979-06-08 1979-06-08
US06/126,078 US4288549A (en) 1979-06-08 1980-03-03 Method of producing the A-30912 antibiotics

Publications (1)

Publication Number Publication Date
DK244680A true DK244680A (da) 1980-12-09

Family

ID=26724253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK244680A DK244680A (da) 1979-06-08 1980-06-06 Fremgangsmaade til fremstilling af antibiotika benaevnt a-30912samt de individuelle faktorer a-30912a,b,d og h.

Country Status (17)

Country Link
US (1) US4288549A (xx)
EP (1) EP0021684A1 (xx)
JP (1) JPS5635988A (xx)
AR (1) AR222553A1 (xx)
AU (1) AU5901580A (xx)
CA (1) CA1154695A (xx)
DD (1) DD153213A5 (xx)
DK (1) DK244680A (xx)
ES (1) ES492227A0 (xx)
FI (1) FI801772A (xx)
FR (1) FR2458587A1 (xx)
GB (1) GB2058078A (xx)
GR (1) GR69261B (xx)
IT (1) IT1209228B (xx)
PL (1) PL224774A1 (xx)
PT (1) PT71349A (xx)
RO (1) RO79494B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product
US4931352A (en) * 1987-10-07 1990-06-05 Merck & Co., Inc. Antifungal fermentation product
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
JPH0370872U (xx) * 1989-11-06 1991-07-17
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US8560369B2 (en) * 2007-11-01 2013-10-15 Red Hat, Inc. Systems and methods for technical support based on a flock structure
US10282701B2 (en) * 2007-11-20 2019-05-07 Red Hat, Inc. Web-based technical issue assignments based on technical support groups having handled a highest number of technical requests
WO2010008493A2 (en) * 2008-06-25 2010-01-21 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
CN103387975A (zh) 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途
CN103724403B (zh) * 2012-10-12 2018-02-16 重庆乾泰生物医药有限公司 一种棘白菌素b的分离纯化方法和用途
CN114907989B (zh) * 2022-05-09 2023-06-27 中国科学院青岛生物能源与过程研究所 一种阿尼芬净前体棘白菌素b高产菌株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024245A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-30912 and process for production thereof
US4024246A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-22082 and process for production thereof

Also Published As

Publication number Publication date
IT8022585A0 (it) 1980-06-05
EP0021684A1 (en) 1981-01-07
IT1209228B (it) 1989-07-16
FR2458587A1 (fr) 1981-01-02
PL224774A1 (xx) 1981-03-13
JPS5635988A (en) 1981-04-08
DD153213A5 (de) 1981-12-30
AR222553A1 (es) 1981-05-29
GR69261B (xx) 1982-05-12
RO79494A (fr) 1982-07-06
RO79494B (ro) 1987-08-31
GB2058078A (en) 1981-04-08
FI801772A (fi) 1980-12-09
ES8105149A1 (es) 1981-05-16
PT71349A (en) 1980-07-01
US4288549A (en) 1981-09-08
AU5901580A (en) 1981-01-22
CA1154695A (en) 1983-10-04
ES492227A0 (es) 1981-05-16

Similar Documents

Publication Publication Date Title
NO861445L (no) Naske-sikker kapsel, og fremgangsmaate og anordning for fremstilling av samme.
NO147909C (no) Polykrystallinsk keramisk skummateriale basert paa whitlockitt, og fremgangsmaate til fremstilling derav
DK244680A (da) Fremgangsmaade til fremstilling af antibiotika benaevnt a-30912samt de individuelle faktorer a-30912a,b,d og h.
DK155946C (da) Fremgangsmaade til fremstilling af 4,1',6'-trichlor-4,1',6'-tridesoxygalactosaccharose
NL7709199A (nl) Vaatprothese, alsmede werkwijze ter vervaardiging ervan.
NO801448L (no) Sikteapparat.
NL186026C (nl) Klemketting.
DK143401C (da) Fremgangsmaade til fremstilling af 3-substituerede 6a,10a-trans-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo-(b,d)pyran-9-oner
DK163517C (da) Fremgangsmaade til fremstilling af 4'-epidaunorubicin og 3',4'-diepidaunorubicin
NO148307C (no) Prosjektil for glattloepet vaapen og fremgangsmaate for fremstilling av samme.
IT1209378B (it) Procedimento per preparare copolimeri.
DK148498C (da) Kontinuerlig fremgangsmaade til fremstilling af mikrokapsler.
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
OA06691A (fr) Phénylurées.
NL185265C (nl) Urineerhulpmiddel.
DK46587A (da) Fremgangsmaade til fremstilling af gamma-globuliner, der kan adminstreres intravenoest, og de opnaaede gamma-globuliner
DK460780A (da) Pyridothienotriaziner og pyridothienotriazinoner samt fremgangsmaade til fremstilling heraf
DK589483D0 (da) Mikrobiel loebe, fremgangsmade til fremstilling deraf og plasmider til anvendelse ved fremgangsmaden
NL187162C (nl) Kwaternaire acrylamides en methacrylamides, alsmede bereidingswijze daarvoor.
DK328280A (da) Fremgangsmaade til fremstilling af 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazon og mellemprodukter herved
NL8004366A (nl) 25-halocholest-5-een-3beta,22-diolen en hun bereiding.
DK248878A (da) Deuterede 1,1,-difluor-2,2-dihalogenethyl-difluormethylethere og fremgangsmaade til fremstilling deraf
DK135401B (da) Vækstmediumenhed og fremgangsmåde til fremstilling af samme.
IT8021374A0 (it) Antibiotico e procedimento per lasua produzione.
DK144885C (da) Fremgangsmaade til fremstilling af 3-substituerede cis-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)-pyran-9-oner